InVivo Therapeutics Holdings - 13 Year Stock Price History | NVIVQ

Historical daily share price chart and data for InVivo Therapeutics Holdings since 2011 adjusted for splits and dividends. The latest closing stock price for InVivo Therapeutics Holdings as of July 19, 2024 is 0.37.
  • The all-time high InVivo Therapeutics Holdings stock closing price was 425250.00 on July 22, 2013.
  • The InVivo Therapeutics Holdings 52-week high stock price is 0.00, which is -100% above the current share price.
  • The InVivo Therapeutics Holdings 52-week low stock price is 0.00, which is 100% below the current share price.
  • The average InVivo Therapeutics Holdings stock price for the last 52 weeks is 0.00.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
InVivo Therapeutics Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 0.4032 0.7900 0.7900 0.2100 0.3700 -49.32%
2023 1.3140 2.2900 2.6300 0.6000 0.7300 -68.94%
2022 5.6753 13.2500 13.5000 1.7600 2.3500 -79.57%
2021 19.8492 20.5000 44.5000 11.5000 11.5000 -43.21%
2020 58.7016 157.5000 255.0000 13.2500 20.2500 -87.73%
2019 682.8869 1222.5000 1282.5000 97.5000 165.0000 -85.43%
2018 4858.7151 17062.5000 17062.5000 1050.0000 1132.5000 -92.16%
2017 47184.2629 77812.5000 92812.5000 14250.0000 14437.5000 -81.67%
2016 109862.3631 136312.0000 184688.0000 68625.0000 78750.0000 -41.67%
2015 202994.0317 97500.0000 333375.0000 97500.0000 135000.0000 36.36%
2014 100752.9762 168000.0000 195000.0000 37500.0000 99000.0000 -42.61%
2013 197354.1667 131250.0000 425250.0000 82500.0000 172500.0000 32.18%
2012 159726.0000 209250.0000 213000.0000 96000.0000 130500.0000 -36.73%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.000B $0.000B
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.385B 19.60
Medtronic (MDT) Ireland $119.983B 16.40
Stryker (SYK) United States $108.118B 20.21
EssilorLuxottica (ESLOY) France $79.433B 0.00
Boston Scientific (BSX) United States $65.288B 14.03
Lonza Group Ag (LZAGY) Switzerland $45.930B 0.00
Medline (MDLN) United States $42.846B 0.00
Agilent Technologies (A) United States $41.387B 24.22
ResMed (RMD) United States $32.167B 19.96
GE HealthCare Technologies (GEHC) United States $29.021B 13.88
Koninklijke Philips (PHG) Netherlands $24.651B 13.13
Terumo (TRUMY) Japan $21.625B 20.65
Zimmer Biomet Holdings (ZBH) United States $18.414B 11.38
Baxter (BAX) United States $12.336B 11.64
Smith & Nephew SNATS (SNN) United Kingdom $11.926B 0.00
Bio-Rad Laboratories (BIO) United States $9.854B 39.71
Demant (WILYY) Denmark $9.592B 0.00
Insulet (PODD) United States $9.557B 23.48
Sunny Optical Technology (SNPTF) China $9.142B 0.00
Lantheus Holdings (LNTH) United States $6.548B 20.15
Raia Drogasil SA - (RADLY) $4.931B 0.00
Haemonetics (HAE) United States $4.837B 21.22
BillionToOne (BLLN) United States $4.757B 144.03
DiaSorin S.p.A (DSRLF) Italy $4.705B 0.00
Envista Holdings (NVST) United States $4.142B 17.54
ICU Medical (ICUI) United States $3.939B 23.52
AtriCure (ATRC) United States $2.838B 242.57
Neogen (NEOG) United States $2.606B 45.96
Curaleaf Holdings (CURLD) Canada $2.388B 0.00
Curaleaf Holdings (CURLF) United States $2.356B 0.00
Prestige Consumer Healthcare (PBH) United States $2.256B 10.77
Trulieve Cannabis (TRLV) United States $2.238B 0.00
GN Store Nord (GNNDY) Denmark $2.207B 0.00
Perrigo (PRGO) Ireland $1.894B 5.46
LeMaitre Vascular (LMAT) United States $1.847B 29.69
Shandong Weigao Medical Polymer (SHWGF) China $1.798B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.736B 0.00
BioLife Solutions (BLFS) United States $1.733B 221.44
Phibro Animal Health (PAHC) United States $1.459B 11.20
Green Thumb Industries (GTBIF) United States $1.428B 15.23
Kestra Medical Technologies (KMTS) United States $1.410B 0.00
Omeros (OMER) United States $1.264B 6.40
Lumexa Imaging Holdings (LMRI) United States $1.094B 0.00
CeriBell (CBLL) United States $0.934B 0.00
InMode (INMD) Israel $0.856B 11.91
AdaptHealth (AHCO) United States $0.802B 16.80
VAREX IMAGING (VREX) United States $0.777B 17.09
QuidelOrtho (QDEL) United States $0.763B 8.24
Glass House Brands (GLAS) United States $0.760B 0.00
Valneva SE (VALN) France $0.633B 0.00
Vireo Growth (VREOF) United States $0.582B 0.00
Tilray Brands (TLRY) Canada $0.564B 0.00
Brainsway (BWAY) Israel $0.548B 30.98
Evolus (EOLS) United States $0.524B 0.00
Cerus (CERS) United States $0.514B 0.00
Capricor Therapeutics (CAPR) United States $0.512B 0.00
Vireo Growth (VREOD) United States $0.451B 0.00
Verano Holdings (VRNO) United States $0.438B 0.00
Verano Holdings (VRNOD) United States $0.425B 0.00
Canopy Growth (CGC) Canada $0.422B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.395B 8.28
Cresco Labs (CRLBF) United States $0.373B 0.00
SNDL (SNDL) Canada $0.353B 0.00
Village Farms (VFF) Canada $0.347B 15.78
Viemed Healthcare (VMD) United States $0.337B 24.56
Sanara MedTech (SMTI) United States $0.321B 159.00
TriSalus Life Sciences (TLSI) United States $0.294B 0.00
MacroGenics (MGNX) United States $0.268B 0.00
Aurora Cannabis (ACB) Canada $0.247B 13.14
High Tide (HITI) Canada $0.234B 52.60
OraSure Technologies (OSUR) United States $0.232B 0.00
Utah Medical Products (UTMD) United States $0.225B 21.55
Owens & Minor (OMI) United States $0.217B 2.17
TerrAscend (TSNDF) Canada $0.205B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.194B 0.00
Exagen (XGN) United States $0.178B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Jin Medical (ZJYL) China $0.155B 0.00
Organigram Global (OGI) Canada $0.152B 0.00
Apyx Medical (APYX) United States $0.127B 0.00
Quanterix (QTRX) United States $0.118B 0.00
Fonar (FONR) United States $0.115B 16.53
ImmuCell (ICCC) United States $0.088B 121.38
Accendra Health (ACH) United States $0.086B 4.87
FitLife Brands (FTLF) United States $0.086B 11.30
Jushi Holdings (JUSHF) United States $0.083B 0.00
Sharps Technology (STSS) United States $0.065B 0.00
InterCure (INCR) Israel $0.058B 0.00
Hongchang (HCIL) China $0.052B 0.00
Biote (BTMD) United States $0.050B 4.12
Nephros (NEPH) United States $0.048B 40.27
Veru (VERU) United States $0.040B 0.00
Sanuwave Health (SNWV) United States $0.037B 17.71
United-Guardian (UG) United States $0.033B 13.26
Rockwell Medical (RMTI) United States $0.031B 0.00
Cellectar Biosciences (CLRB) United States $0.022B 0.00
Modular Medical (MODD) United States $0.021B 0.00
Cytosorbents (CTSO) United States $0.019B 0.00
Bonk (BNKK) United States $0.011B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Agape ATP (ATPC) $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
IM Cannabis (IMCC) Canada $0.000B 0.00
INLIF (INLF) China $0.000B 0.00